Editorial: Treatment and Prognostic Assessment of Liver Cirrhosis and Its Complications, Volume II

The editorial summarizes 21 papers on liver cirrhosis and its complications, highlighting key findings in symptoms, pathogenesis, cancer assessment, portal hypertension, prognosis, and treatment. Notable studies include a meta-analysis showing a 27% prevalence of frailty in cirrhosis patients, research on the role of Chitinase-3-like protein 1 in liver fibrosis, and a nomogram predicting survival in hepatocellular carcinoma patients. Innovative diagnostic methods for portal hypertension and effective treatments for cirrhosis-related complications, such as probiotics for hepatic encephalopathy, are also discussed. The findings aim to impact clinical practice and pave the way for future research.